During the past decade, Hopital Bellevue conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Bellevue" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials, followed by "Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "ANRS, Emerging Infectious Diseases" with 1 trials sponsored and "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Bellevue" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator and "University Hospital, Grenoble" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Bellevue" are "Type 1 Diabetes" (2 trials), "Alzheimer's Disease" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Blepharospasm" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Hopital Bellevue" in a lesser frequency.

Most popular intervention types in "Hopital Bellevue" are "Drug" (5 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (3 trials), "Blood sampling, skin biopsy" (1 trials), "Etanercept" (1 trials), "FOLFOX regimen" (1 trials) and "LPV400mg/RTV100mgBID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Bellevue" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital Bellevue". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hopital Bellevue, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Bellevue, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".